BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 22112287)

  • 1. Changing patterns (age, incidence, and pathologic types) of schistosoma-associated bladder cancer in Egypt in the past decade.
    Salem HK; Mahfouz S
    Urology; 2012 Feb; 79(2):379-83. PubMed ID: 22112287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changing age incidence and pathological types of schistosoma-associated bladder carcinoma.
    Koraitim MM; Metwalli NE; Atta MA; el-Sadr AA
    J Urol; 1995 Nov; 154(5):1714-6. PubMed ID: 7563329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carcinoma of the urinary bladder associated with schistosomiasis in Egypt: the possible causal relationship.
    Tawfik HN
    Princess Takamatsu Symp; 1987; 18():197-209. PubMed ID: 3147281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of schistosomiasis on urinary bladder cancer in the southern province of Saudi Arabia: review of 60 cases.
    Khurana P; Morad N; Khan AR; Shetty S; Ibrahim A; Patil K
    J Trop Med Hyg; 1992 Apr; 95(2):149-51. PubMed ID: 1560487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alterations affecting the p53 control pathway in bilharzial-related bladder cancer.
    Osman I; Scher HI; Zhang ZF; Pellicer I; Hamza R; Eissa S; Khaled H; Cordon-Cardo C
    Clin Cancer Res; 1997 Apr; 3(4):531-6. PubMed ID: 9815716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bladder cancer in Lagos: a 15 year histopathologic review.
    Anunobi CC; Banjo AA; Abdulkareem FB; Daramola AO; Akinde OR; Elesha SO
    Niger Postgrad Med J; 2010 Mar; 17(1):40-4. PubMed ID: 20348981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence analyses of bladder cancer in the Nile delta region of Egypt.
    Fedewa SA; Soliman AS; Ismail K; Hablas A; Seifeldin IA; Ramadan M; Omar HG; Nriagu J; Wilson ML
    Cancer Epidemiol; 2009 Oct; 33(3-4):176-81. PubMed ID: 19762298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic inflammation and bladder cancer.
    Michaud DS
    Urol Oncol; 2007; 25(3):260-8. PubMed ID: 17483025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carcinogenic risks of some biological agents.
    Attah E
    Lancet; 1995 May; 345(8961):1376. PubMed ID: 7752790
    [No Abstract]   [Full Text] [Related]  

  • 10. The clinical value of CYFRA21-1 in bladder cancer patients: Egyptian experience.
    el-Ahmady O; Halim AB; el-Din AG
    Anticancer Res; 1999; 19(4A):2603-8. PubMed ID: 10470202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bladder cancer in Africa.
    Heyns CF; van der Merwe A
    Can J Urol; 2008 Feb; 15(1):3899-908. PubMed ID: 18304401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histopathological study of vesical carcinoma in Plateau State, Nigeria.
    Obafunwa JO
    Eur J Surg Oncol; 1991 Oct; 17(5):489-91. PubMed ID: 1936295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The incidence of squamous and transitional cell carcinomas of the urinary bladder in northern Tanzania in areas of high and low levels of endemic Schistosoma haematobium infection.
    Kitinya JN; Laurèn PA; Eshleman LJ; Paljärvi L; Tanaka K
    Trans R Soc Trop Med Hyg; 1986; 80(6):935-9. PubMed ID: 3111028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chromosomal aberrations in Cis and Ta bilharzial bladder cancer: a theory of pathogenesis.
    Khaled HM; Aly MS; Mokhtar N
    Urol Oncol; 2004; 22(6):443-7. PubMed ID: 15610858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The changing patterns of bladder cancer in Egypt over the past 26 years.
    Felix AS; Soliman AS; Khaled H; Zaghloul MS; Banerjee M; El-Baradie M; El-Kalawy M; Abd-Elsayed AA; Ismail K; Hablas A; Seifeldin IA; Ramadan M; Wilson ML
    Cancer Causes Control; 2008 May; 19(4):421-9. PubMed ID: 18188671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Bladder cancers in Senegal: epidemiological, clinical and histological features].
    Diao B; Amath T; Fall B; Fall PA; Diémé MJ; Steevy NN; Ndoye AK; Ba M; Mendes V; Diagne BA
    Prog Urol; 2008 Jul; 18(7):445-8. PubMed ID: 18602605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bilharzial vs non-bilharzial related bladder cancer: pathological characteristics and value of cyclooxygenase-2 expression.
    Youssef R; Kapur P; Kabbani W; Shariat SF; Mosbah A; Abol-Enein H; Ghoniem M; Lotan Y
    BJU Int; 2011 Jul; 108(1):31-7. PubMed ID: 21105986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bilharzial related, organ confined, muscle invasive bladder cancer: prognostic value of apoptosis markers, proliferation markers, p53, E-cadherin, epidermal growth factor receptor and c-erbB-2.
    Haitel A; Posch B; El-Baz M; Mokhtar AA; Susani M; Ghoneim MA; Marberger M
    J Urol; 2001 May; 165(5):1481-7. PubMed ID: 11342901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pattern of bladder cancer in the Sudan and its relation to schistosomiasis: a study of 255 vesical carcinomas.
    Malik MO; Veress B; Daoud EH; El-Hassan AM
    J Trop Med Hyg; 1975; 78(10-11):219-23. PubMed ID: 1214307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.